A Study of SGB-7342 in Subjects With Obesity or Overweight
Status:
NOT_YET_RECRUITING
Trial end date:
2027-04-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of subcutaneously administered SGB-7342 in adult subjects with obesity and overweight.